Crispr Therapeutics Email Format

Biotechnology Research
201-500 employees
Boston, MA, USA

Crispr Therapeutics is a biotechnology company pioneering CRISPR-based gene editing therapies for hemoglobinopathies, oncology, cardiovascular, and rare diseases worldwide.

Find contacts at Crispr Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@crisprtx.com

Company Overview

Industry
Biotechnology Research
Founded
2013
Headquarters
Boston, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Public
Key Executives
Samarth Kulkarni (Chief Executive Officer and Chairman of the Board), Raju Prasad, Ph.D. (Chief Financial Officer), Stephen Kennedy (Head of Technical Operations)

Tech Stack

Okta

Security

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Crispr Therapeutics?

Crispr Therapeutics uses the first.last format, so Jane Smith would be jane.smith@crisprtx.com.

What approved product does Crispr Therapeutics currently sell?

Crispr Therapeutics co-developed CASGEVY (exa-cel), the first approved CRISPR-based gene therapy for sickle cell disease and transfusion-dependent beta-thalassemia. It has received regulatory approval in the U.S., UK, EU, Canada, and several other countries for patients aged 12 and older.

How broad is the Crispr Therapeutics pipeline beyond hemoglobinopathies in 2026?

Beyond hemoglobinopathies, Crispr Therapeutics is advancing programs in cardiovascular disease, autoimmune conditions, oncology, and rare diseases including AATD, using both its CRISPR/Cas9 and proprietary SyNTase gene-editing platforms.

Who leads Crispr Therapeutics as CEO in 2026?

Samarth Kulkarni serves as Chief Executive Officer and Chairman of the Board at Crispr Therapeutics. Tools like Clay can help you find and verify his contact details or identify other senior leaders at the company for outreach.

Where is Crispr Therapeutics headquartered and how large is the company?

Crispr Therapeutics is headquartered in Boston, MA, and employs approximately 359 people. If you need to reach a specific team or verify an employee email before outreach, Clay can help enrich and confirm those contact details.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles